Tag: Nmda receptors

In August 2022, the FDA approved a new medication called Auvelity, which combines bupropion with dextromethorphan for major depressive disorder (MDD). This represents a significant advancement in medications regarding what is the new drug for bupropion, as it offers a novel approach to treating depression.

Dissociative drugs cause feelings of detachment from one's body and environment by altering the function of the neurotransmitter glutamate in the brain. To answer the question, **what is a dissociative drug**, we must explore its unique mechanism of action and the effects it produces.

While caffeine famously blocks adenosine receptors to produce its stimulant effect, early animal research suggests agmatine might specifically dampen some of caffeine's stimulant properties in a dose- and sex-dependent manner. This surprising interaction highlights the intricate ways different compounds can influence neurochemistry, but human data remains sparse.